✦ LIBER ✦

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

✍ Scribed by Christopher M. O'Connor; Alan B. Miller; John E.A. Blair; Marvin A. Konstam; Patricia Wedge; Maria C. Bahit; Peter Carson; Markus Haass; Paul J. Hauptman; Marco Metra; Ron M. Oren; Richard Patten; Ileana Piña; Sherryn Roth; Jonathan D. Sackner-Bernstein; Brian Traver; Thomas Cook; Mihai Gheorghiade

Book ID: 116192070
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 267 KB
Volume: 159
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2010.02.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gender Does Not Affect Postdischarge Out

Gender Does Not Affect Postdischarge Outcomes in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan [EVEREST] Trial)

✍ Ami N. Shah; Robert J. Mentz; Mihai Gheorghiade; Mary J. Kwasny; Angela J. Fough 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 360 KB

EVEREST (Efficacy of Vasopressin Antagon

EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan)

📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Continental Differences in Clinical Char

Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program

✍ John E.A. Blair; Faiez Zannad; Marvin A. Konstam; Thomas Cook; Brian Traver; Joh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Comparison of One-Year Outcome (Death an

Comparison of One-Year Outcome (Death and Rehospitalization) in Hospitalized Heart Failure Patients With Left Ventricular Ejection Fraction >50% Versus Those With Ejection Fraction <50%

✍ Justin A. Ezekowitz; Douglas S. Lee; Jack V. Tu; Alice M. Newman; Finlay A. McAl 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Effects of tolvaptan on physician-assess

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials

✍ Peter S. Pang; Mihai Gheorghiade; Jamil Dihu; Karl Swedberg; Sadiya Khan; Aldo P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Differential impact of heart rate and bl

Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction

✍ Micha T. Maeder; David M. Kaye 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 801 KB